Measuring and improving the timeliness of vancomycin therapeutic drug monitoring and potential patient safety impacts

Measuring and improving the timeliness of vancomycin therapeutic drug monitoring and potential patient safety impacts

Background: Timely vancomycin therapeutic drug monitoring (TDM) enables prompt dose adjustments and safe treatment. Local incidents prompted an investigation into the reasons for prolonged reporting times. Objectives: To investigate the variation in reporting times of vancomycin concentrations betwe...

Full description

Bibliographic Details
Main Authors:	Belinda Chappell, Benita Suckling, Champika Pattullo
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Exploratory Research in Clinical and Social Pharmacy
Subjects:	Vancomycin Therapeutic drug monitoring On-site Reporting Systems change Quality improvement
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667276623001841

Similar Items

Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients
by: Yun Kim, et al.
Published: (2022-01-01)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021-12-01)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023-06-01)

Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections
by: O. S. Tufanova, et al.
Published: (2022-07-01)

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis
by: A. B. Prokofiev, et al.
Published: (2022-07-01)

What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value
by: Bruce R. Dalton
Published: (2023-02-01)

Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies
by: Matylda Resztak, et al.
Published: (2021-11-01)

Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring
by: Ashley Chen, et al.
Published: (2022-12-01)

Extremely high levels of vancomycin can cause severe renal toxicity
by: Barceló-Vidal J, et al.
Published: (2018-07-01)

The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
by: Paul Firman, et al.
Published: (2022-12-01)

Therapeutic Drug Monitoring of Vancomycin Concentrations for the Management of Bone and Joint Infections: An Urgent Need
by: Laura Rio-No, et al.
Published: (2023-02-01)

Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring
by: Abdullah Aljutayli, et al.
Published: (2022-11-01)

Experience of Vancomycin Therapeutic Drug Monitoring in Two Multidisciplinary Hospitals in Latvia
by: Inga Mauliņa, et al.
Published: (2022-03-01)

Vancomycin treatment: analysis of efficacy and safety
by: Brigita Mavsar-Najdenov, et al.
Published: (2007-11-01)

Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults
by: Heleen Gastmans, et al.
Published: (2022-07-01)

Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis
by: Xiaowu Zhang, et al.
Published: (2024-01-01)

Case report: therapeutic monitoring of vancomycin in an acute liver failure patient with anuria under high-flow continuous hemodiafiltration
by: Yuriko Ito, et al.
Published: (2023-05-01)

Is vancomycin monitoring of real value in pediatric cancer patients?
by: Mohamed S. Imam, et al.
Published: (2018-03-01)

Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental Study
by: Yazed Saleh Alsowaida, et al.
Published: (2022-09-01)

Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
by: Oscar Santalo, et al.
Published: (2016-11-01)

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
by: Kazuaki Matsumoto, et al.
Published: (2022-02-01)

Junior doctors’ preparedness to prescribe, monitor, and treat patients with the antibiotic vancomycin in an Australian teaching hospital
by: Cameron J Phillips, et al.
Published: (2017-06-01)

Simple and rapid method for analysis of urinary vancomycin using solid phase extraction and fluorescence spectroscopy
by: Yuki Oshima, et al.
Published: (2023-02-01)

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01)

Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy
by: Wen-Hsien Ho, et al.
Published: (2023-03-01)

Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management
by: Soo Hyeon Bae, et al.
Published: (2019-05-01)

Vancomycin Flight Simulator: A Team-Based Learning Exercise
by: Nicholas W. Carris, et al.
Published: (2023-01-01)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
by: Wasan Katip, et al.
Published: (2021-08-01)

A Risk Prediction Flowchart of Vancomycin-Induced Acute Kidney Injury to Use When Starting Vancomycin Administration: A Multicenter Retrospective Study
by: Takayuki Miyai, et al.
Published: (2020-12-01)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021-11-01)

Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
by: Adam Frymoyer, et al.
Published: (2020-04-01)

Impact of Pharmacist-Led Multidisciplinary Team to Attain Targeted Vancomycin Area under the Curved Monitoring in a Tertiary Care Center in Thailand
by: Kittiya Jantarathaneewat, et al.
Published: (2023-02-01)

Clinical Relevance of a Vancomycin 24 h Area under the Concentration—Time Curve Values Using Different Renal Function Equations in Bayesian Dosing Software
by: Hyun-Ki Kim, et al.
Published: (2023-01-01)

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
by: Lore Thijs, et al.
Published: (2022-05-01)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
by: Maluangnon C, et al.
Published: (2022-12-01)

A descriptive study of vancomycin use at Red Cross War Memorial Children’s Hospital, Cape Town
by: Leonore Greybe, et al.
Published: (2023-11-01)

Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring
by: Abrar F Alhameed, et al.
Published: (2019-02-01)

Local Vancomycin Usage for Prophylaxis of Surgical Site Infections
by: Emre KARA, et al.
Published: (2020-03-01)

Administration and Therapeutic Drug Monitoring of <i>β-lactams</i> and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study
by: Yuli V. Fuentes, et al.
Published: (2021-09-01)

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations
by: Kritsaporn Sujjavorakul, et al.
Published: (2023-03-01)